#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa


Background:
The World Health Organization estimates that in sub-Saharan Africa about 4 million HIV-infected patients had started antiretroviral therapy (ART) by the end of 2008. Loss of patients to follow-up and care is an important problem for treatment programmes in this region. As mortality is high in these patients compared to patients remaining in care, ART programmes with high rates of loss to follow-up may substantially underestimate mortality of all patients starting ART.

Methods and Findings:
We developed a nomogram to correct mortality estimates for loss to follow-up, based on the fact that mortality of all patients starting ART in a treatment programme is a weighted average of mortality among patients lost to follow-up and patients remaining in care. The nomogram gives a correction factor based on the percentage of patients lost to follow-up at a given point in time, and the estimated ratio of mortality between patients lost and not lost to follow-up. The mortality observed among patients retained in care is then multiplied by the correction factor to obtain an estimate of programme-level mortality that takes all deaths into account. A web calculator directly calculates the corrected, programme-level mortality with 95% confidence intervals (CIs). We applied the method to 11 ART programmes in sub-Saharan Africa. Patients retained in care had a mortality at 1 year of 1.4% to 12.0%; loss to follow-up ranged from 2.8% to 28.7%; and the correction factor from 1.2 to 8.0. The absolute difference between uncorrected and corrected mortality at 1 year ranged from 1.6% to 9.8%, and was above 5% in four programmes. The largest difference in mortality was in a programme with 28.7% of patients lost to follow-up at 1 year.

Conclusions:
The amount of bias in mortality estimates can be large in ART programmes with substantial loss to follow-up. Programmes should routinely report mortality among patients retained in care and the proportion of patients lost. A simple nomogram can then be used to estimate mortality among all patients who started ART, for a range of plausible mortality rates among patients lost to follow-up.

: Please see later in the article for the Editors' Summary


Vyšlo v časopise: Correcting Mortality for Loss to Follow-Up: A Nomogram Applied to Antiretroviral Treatment Programmes in Sub-Saharan Africa. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000390
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000390

Souhrn

Background:
The World Health Organization estimates that in sub-Saharan Africa about 4 million HIV-infected patients had started antiretroviral therapy (ART) by the end of 2008. Loss of patients to follow-up and care is an important problem for treatment programmes in this region. As mortality is high in these patients compared to patients remaining in care, ART programmes with high rates of loss to follow-up may substantially underestimate mortality of all patients starting ART.

Methods and Findings:
We developed a nomogram to correct mortality estimates for loss to follow-up, based on the fact that mortality of all patients starting ART in a treatment programme is a weighted average of mortality among patients lost to follow-up and patients remaining in care. The nomogram gives a correction factor based on the percentage of patients lost to follow-up at a given point in time, and the estimated ratio of mortality between patients lost and not lost to follow-up. The mortality observed among patients retained in care is then multiplied by the correction factor to obtain an estimate of programme-level mortality that takes all deaths into account. A web calculator directly calculates the corrected, programme-level mortality with 95% confidence intervals (CIs). We applied the method to 11 ART programmes in sub-Saharan Africa. Patients retained in care had a mortality at 1 year of 1.4% to 12.0%; loss to follow-up ranged from 2.8% to 28.7%; and the correction factor from 1.2 to 8.0. The absolute difference between uncorrected and corrected mortality at 1 year ranged from 1.6% to 9.8%, and was above 5% in four programmes. The largest difference in mortality was in a programme with 28.7% of patients lost to follow-up at 1 year.

Conclusions:
The amount of bias in mortality estimates can be large in ART programmes with substantial loss to follow-up. Programmes should routinely report mortality among patients retained in care and the proportion of patients lost. A simple nomogram can then be used to estimate mortality among all patients who started ART, for a range of plausible mortality rates among patients lost to follow-up.

: Please see later in the article for the Editors' Summary


Zdroje

1. World Health Organization 2009 Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. 2009 Progress Report. WHO, Geneva. Available: http://www.who.int/hiv/pub/2009progressreport/en/index.html. Accessed 6 December 2010

2. GilksCF

CrowleyS

EkpiniR

GoveS

PerriensJ

2006 The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 368 505 510

3. IversLC

KendrickD

DoucetteK

2005 Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 41 217 224

4. KeiserO

OrrellC

EggerM

WoodR

BrinkhofMW

2008 Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland compared. PLoS Med 5 e148 doi:10.1371/journal.pmed.0050148

5. MillsEJ

NachegaJB

BuchanI

OrbinskiJ

AttaranA

2006 Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA 296 679 690

6. RosenS

FoxMP

GillCJ

2007 Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4 e298 doi:10.1371/journal.pmed.0040298

7. BrinkhofMW

DabisF

MyerL

BangsbergDR

BoulleA

2008 Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ 86 559 567

8. BrinkhofMW

Pujades-RodriguezM

EggerM

2009 Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One 4 e5790 doi:10.1371/journal.pone.0005790

9. MayM

BoulleA

PhiriS

MessouE

MyerL

2010 Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet 376 449 457

10. GrimesDA

2008 The nomogram epidemic: resurgence of a medical relic. Ann Intern Med 149 273 275

11. PortaM

2008 A Dictionary of Epidemiology. Fifth Edition. Oxford University Press 167

12. AnglaretX

ToureS

GourvellecG

TchehyA

ZioL

2004 Impact of vital status investigation procedures on estimates of survival in cohorts of HIV-infected patients from sub-Saharan Africa. J Acquir Immune Defic Syndr 35 320 323

13. YuJK

ChenSC

WangKY

ChangCS

MakombeSD

2007 True outcomes for patients on antiretroviral therapy who are “lost to follow-up” in Malawi. Bull World Health Organ 85 550 554

14. DalalRP

MacPhailC

MqhayiM

WingJ

FeldmanC

2008 Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr 47 101 107

15. FoxMP

BrennanA

MaskewM

MacPhailP

SanneI

2010 Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Health 15 405 413

16. DabisF

BalestreE

BraitsteinP

MiottiP

BrinkhofWGM

2005 Antiretroviral Therapy in Lower Income Countries (ART-LINC): International collaboration of treatment cohorts. Int J Epidemiol 34 979 986

17. KeiserO

AnastosK

SchechterM

BalestreE

MyerL

2008 Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health 13 870 879

18. ForsterM

BaileyC

BrinkhofMW

GraberC

BoulleA

2008 Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings. Bull World Health Organ 86 939 947

19. McGowanCC

CahnP

GotuzzoE

PadgettD

PapeJW

2007 Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol 36 969 976

20. GangeSJ

KitahataMM

SaagMS

BangsbergDR

BoschRJ

2007 Cohort profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol 36 294 301

21. InuiTS

NyandikoWM

KimaiyoSN

FrankelRM

MuriukiT

2007 AMPATH: Living proof that no one has to die from HIV. J Gen Intern Med 22 1745 1750

22. EinterzRM

KimaiyoS

MengechHN

Khwa-OtsyulaBO

EsamaiF

2007 Responding to the HIV pandemic: the power of an academic medical partnership. Acad Med 82 812 818

23. YiannoutsosCT

AnMW

FrangakisCE

MusickBS

BraitsteinP

2008 Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One 3 e3843 doi:10.1371/journal.pone.0003843

24. FrangakisCE

RubinDB

2001 Addressing an idiosyncrasy in estimating survival curves using double sampling in the presence of self-selected right censoring. Biometrics 57 333 342

25. GengEH

BangsbergDR

MusinguziN

EmenyonuN

BwanaMB

2010 Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach. J Acquir Immune Defic Syndr 53 405 411

26. StringerJS

ZuluI

LevyJ

StringerEM

MwangoA

2006 Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296 782 793

27. BraitsteinP

BrinkhofMW

DabisF

SchechterM

BoulleA

2006 Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and high-income countries. Lancet 367 817 824

28. FerradiniL

JeanninA

PinogesL

IzopetJ

OdhiamboD

2006 Scaling up of highly active antiretroviral therapy in a rural district of Malawi: An effectiveness assessment. Lancet 367 1335 1342

29. BoulleA

BockP

OslerM

CohenK

ChanningL

2008 Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ 86 678 687

30. GengEH

EmenyonuN

BwanaMB

GliddenDV

MartinJN

2008 Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA 300 506 507

31. LosinaE

ToureH

UhlerLM

AnglaretX

PaltielAD

2009 Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: A Cote d'Ivoire appraisal. PLoS Med 6 e1000173 doi:10.1371/journal.pmed.1000173

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2011 Číslo 1
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#